Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2012

Jan 10, 2012

34975_dirs_2012-01-10_2570db47-f506-462a-8fa3-126d976075a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-01-09

Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-01-09 Common Stock F 7656 $3.87 Disposed 294353 Direct

Footnotes

F1: The shares were disposed to satisfy Ms. Luscinski's tax withholding obligation in connection with deferred stock awards granted to Ms. Luscinski on June 4, 2010 and June 2, 2011 both of which vested in part on January 1, 2012.

F2: Includes (a) a deferred stock award of 33,400 restricted stock units which vest in equal installments on January 1, 2013 and January 1, 2014; (b) a deferred stock award of 14,062 restricted stock units which vest in equal installments on January 1, 2013; January 1, 2014 and January 1, 2015; and (c) 246,891 shares of common stock held by Ms. Luscinski.